Table 2.
Control group (n = 10) | Low-dose group (n = 10) | High-dose group (n = 10) | Among-group P-value# | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Median | P25 | P75 | Median | P25 | P75 | Median | P25 | P75 | |||
Total dietary intakes of vitamin B12 including nori (µg/day)† | Pre | 0.8 | 0.7 | 2.4 | 0.3 | 0.2 | 1.0 | 0.5 | 0.4 | 0.8 | 0.21 |
Post | 0.9 | 0.3 | 1.6 | 2.0 ** | 1.9 | 2.8 | 3.5 ** | 3.3 | 4.1 | 0.0003 | |
Dietary intakes of vitamin B12 from foods other than nori (µg/day) | Pre | 0.8 | 0.7 | 2.4 | 0.2 | 0.2 | 1.0 | 0.5 | 0.3 | 0.8 | 0.16 |
Post | 0.9 | 0.3 | 1.6 | 0.2 | 0.1 | 1.0 | 0.4 | 0.3 | 0.9 | 0.10 |
Data are presented as median, p25, p75. *P-value < 0.05; **P-value < 0.01 for within-group changes between post-intervention and pre-intervention calculated by Wilcoxon signed-rank test. # Among-group P-value comparison using Kruskal-Wallis test. † Total dietary intake of vitamin B12 at post-intervention included intakes from both non-nori sources and study-prescribed nori provided for intervention groups (nori vitamin B12 calculated using 38.6 µg/100 g assessed by our study)